BJL
RIGL icon

Brighton Jones LLC’s Rigel Pharmaceuticals RIGL Stock Holding History

Brighton Jones LLC’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,900
Closed -$28.1K – 661
2024
Q1 		$28.1K Hold
1,900
– – ﹤0.01% 620
2023
Q4 		$27.6K Hold
1,900
– – ﹤0.01% 570
2023
Q3 		$20.5K Hold
1,900
– – ﹤0.01% 537
2023
Q2 		$24.5K Hold
1,900
– – ﹤0.01% 541
2023
Q1 		$25.1K Hold
1,900
– – ﹤0.01% 512
2022
Q4 		$28.5K Hold
1,900
– – ﹤0.01% 472
2022
Q3 		$22K Hold
1,900
– – ﹤0.01% 458
2022
Q2 		$21K Sell
1,900
-50
-3% -$1K ﹤0.01% 469
2022
Q1 		$58K Buy
1,950
+10
+0.5% +$271 ﹤0.01% 504
2021
Q4 		$51K Hold
1,940
– – ﹤0.01% 521
2021
Q3 		$70K Hold
1,940
– – ﹤0.01% 474
2021
Q2 		$84K Hold
1,940
– – ﹤0.01% 469
2021
Q1 		$66K Hold
1,940
– – ﹤0.01% 423
2020
Q4 		$68K Buy
1,940
+40
+2% +$1.16K ﹤0.01% 389
2020
Q3 		$46K Hold
1,900
– – ﹤0.01% 328
2020
Q2 		$35K Hold
1,900
– – ﹤0.01% 294
2020
Q1 		$30K Buy
1,900
+100
+6% +$2.13K ﹤0.01% 276
2019
Q4 		$39K Hold
1,800
– – ﹤0.01% 317
2019
Q3 		$34K Buy
+1,800
New +$37.2K ﹤0.01% 305

Other funds holding RIGL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Brighton Jones LLC's RIGL Position: Q2 2024 in Review

Brighton Jones LLC sold out of Rigel Pharmaceuticals (RIGL) in Q2 2024, closing a stake of 1,900 shares — an estimated $28.1K sold.

Brighton Jones LLC first reported a position in RIGL in Q3 2019 and held it in 19 quarters. The position peaked at $84K in Q2 2021. 91 funds tracked by Wall St. Rank hold RIGL as of Q2 2024.

  • Brighton Jones LLC reported no remaining Rigel Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Brighton Jones LLC sold 1,900 Rigel Pharmaceuticals shares in Q2 2024, an estimated $28.1K.
  • Brighton Jones LLC first reported a position in Rigel Pharmaceuticals in Q3 2019 and held it in 19 quarters.
  • Brighton Jones LLC's Rigel Pharmaceuticals position peaked at $84K in Q2 2021.
  • 91 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2024.

Based on Brighton Jones LLC's 13F filing for Q2 2024, filed 12 Aug 2024.